About us

Group overview

Lei Yunshang Group is one of the first batch of China's old brands, state top-secret projects and owners of national intangible cultural heritage, and one of the four major pharmacies. Lei Yun Shang was founded in 1734, and it has been nearly 300 years since then. His founder Lei Dasheng (Ziyun Shang, No. Nanshan, 1696-1779) is a famous doctor of Wumen in Qing Dynasty and a master of Wumen Medical School.

Lei Yunshang Group, with its nearly 300-year-old "Lei Yunshang" as its unified brand and "gathering Baicao Zewanmin" as its mission, upholds the brand idea of "300 years Lei Yunshang, inheriting health wisdom", adheres to the ancestral precept of "Selecting genuine medicinal materials, sticking to their faith, spreading ointment and Dan Shangpin" and inherits and develops the essence of febrile disease theory. At present, it has developed into a large healthy industrial cluster of traditional Chinese medicine, which integrates industry, commerce, chain, traditional Chinese medicine, health preservation and medicinal herbs planting. At present, Leiyunshang Pharmaceutical Group has production bases in Suzhou, Changshu, Shenyang, Changchun, Yunfu, Kunming and other places. The main drug varieties of Leiyunshang Group covers more than 400 quasi-brand products of Chinese medicine, including tablets, powder, granules, pills, capsules and ointments. Among them, there are two national intangible cultural heritage projects (traditional Chinese medicine preparation methods of Leiyunshang Liushen pills and representative inheritors of production techniques of Leiyunshang Liushen pills). Liushen Pills, Jianyingling Capsules and other famous prescriptions of the state's top secret formula products.

At present, Lei Yunshan has eight sales departments: hospital department, investment department, commerce department, general medicine department, OTC department, Pediatrics department, anti-cancer department and nephrology department; five management centers: medicine management center, quality management center, production management center, R&D technology center and finance department. Operating Center. The Group has five subsidiaries directly under it: Lei Yunshang Commercial Company, Lei Yunshang Health Care Company, and more than 50 old shops such as Chanfentang, Wang Hongyi, Mutaishan, etc. with private customized service, such as Lei Yunshang Chinese medicine chain, Changshu Lei Yunshang Pharmaceutical Company and Lei Yunshang Ecological Farm; four member enterprises: Shenyang Lei Yunshang, Mu Taishan, etc. Guangdong Lei Yun Shang, Changchun Lei Yun Shang and Yunnan Lei Yun Shang.

Member enterprises:

Changshu Lei Yun Shang Pharmaceutical Co., Ltd., a subsidiary of Leiyunshang Group, located in Changshu High-tech Industrial Park by Shajiabang at the foot of the beautiful Mountain Yu, is a modern production enterprise of traditional Chinese medicine preparation integrating scientific research, production and operation with traditional Chinese medicine injection and oral liquid of traditional Chinese medicine as featured products as well as a high-tech enterprise listed in National Torch Program, a high-tech enterprise in Jiangsu Province, a key enterprise in pharmaceutical industry of Jiangsu Province, a scientifically middle and small-sized enterprise in Jiangsu Province, and an innovative pioneer enterprise in Suzhou.

The total floor area of Changshu Lei Yun Shang is more than 40,000 square meters. The company has plants conforming to GMP, has set drug pre-treatment, extraction of Chinese traditional medicine and three modern production lines of small volume, large volume and oral liquid, and has been equipped with advanced detection instrument to guarantee drug quality. At the beginning of 2013, the company passed field inspection of national GMP certification (new edition) for one time and became one of the first batch of enterprises to receive drug GMP certification (new edition) in China.

Changshu Lei Yun Shang is dedicated to special drugs for liver diseases, expands market in drugs for cardiovascular and cerebrovascular diseases and tumor, has series of drug products for liver diseases, such as kuhuang injection and hepatitis drug injection, and tianfoshen oral liquid, pulse-activating injection and other varieties of Chinese patent medicines.

The company has persisted in the idea of “Quality First”, taken comprehensive implementation of drug GMP management as corporate principle in daily production and quality management, and adhered to comprehensive quality management system for all staff. Meanwhile, the company has received ISO9001 quality management system certification and occupational health and safety management system certification and has been rated as Jiangsu AA-level enterprise for quality credit rating.

Technical Center of the company has been successively listed as Technical Research Center of Jiangsu Modern Chinese Medicine Compound Preparation Project by Jiangsu Provincial Department of Science and Technology, Jiangsu Engineering Center by Jiangsu Development and Reform Commission, and Provincial Enterprise Technology Center by Jiangsu Provincial Commission of Economy and Information Technology. At present, the company has high performance liquid chromatograph, gaschromatograph, NIR spectrophotometer, TOC analyzer, atomic absorption spectrophotometer, and other large detection instruments and complete set of pilot plant research equipment in traditional Chinese medicine extraction refining system as well as automatic integrated manufacturing system of traditional Chinese medicine. Moreover, the company has complete infrastructures and strong capacities of new drug development and technology research.

The company has persisted in driving corporate development based on “Scientific and Technological Innovation and Featured Products”. In recent years, the company has undertaken 4 projects in National Torch Program, a major national science and technology subject, a major transformation project of scientific and technological achievements in Jiangsu, two Jiangsu provincial science and technology support plans, developed a new national key product, two new key products of Jiangsu, four high-tech products of Jiangsu, three independently innovative products of Jiangsu, and one excellent new product of Jiangsu, and been authorized to invent 19 patents. In addition, the company has constantly enriched and improved innovation model, paid more attention to new drug development, actively established enterprise-based, market-oriented, and industry-university-research-combined technology innovation system, enhanced industry-university-research cooperation with higher research institutes and universities and colleges. In recent years, the company has conducted industry-university-research activities with Zhejiang University, Jiangsu Academy of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Shaanxi University of Chinese Medicine, Soochow University, School of Chinese Medicine, Hong Kong Baptist University, and other universities and colleges and scientific research institutes for new drug research and development, technical cooperation, achievement transformation, and joint establishment of technical cooperation platform. The company has established traditional Chinese medicine quality control technology laboratory with Zhejiang University, established Changshu Lei Yun Shang New Drug Research and Development Center with Jiangsu Academy of Traditional Chinese Medicine, and established Suzhou key lab for drug research on high fat disease prevention and treatment and a provincial enterprise-postgraduate work station with Soochow University.

In the future, Changshu Lei Yun Shang will continue to abide by the corporate spirit of “Loyalty, Simplicity, Diligence and Innovation”, develop based on “Production Innovation, Technological Innovation and Management Innovation”, speed up development of competitive new products in the market, vigorously develop the high-tech pharmaceutical industry, establish new advantages in talents, mechanism, resources and environment so as to become a scientifically innovative traditional Chinese medicine enterprise.